134 related articles for article (PubMed ID: 12145342)
21. Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/iodide symporter gene.
Pohlenz J; Medeiros-Neto G; Gross JL; Silveiro SP; Knobel M; Refetoff S
Biochem Biophys Res Commun; 1997 Nov; 240(2):488-91. PubMed ID: 9388506
[TBL] [Abstract][Full Text] [Related]
22. The sodium/iodide symporter: state of the art of its molecular characterization.
Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
[TBL] [Abstract][Full Text] [Related]
23. Iodide transport defect: functional characterization of a novel mutation in the Na+/I- symporter 5'-untranslated region in a patient with congenital hypothyroidism.
Nicola JP; Nazar M; Serrano-Nascimento C; Goulart-Silva F; Sobrero G; Testa G; Nunes MT; Muñoz L; Miras M; Masini-Repiso AM
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1100-7. PubMed ID: 21565787
[TBL] [Abstract][Full Text] [Related]
24. Amino acid residues in transmembrane segment IX of the Na+/I- symporter play a role in its Na+ dependence and are critical for transport activity.
De la Vieja A; Reed MD; Ginter CS; Carrasco N
J Biol Chem; 2007 Aug; 282(35):25290-8. PubMed ID: 17606623
[TBL] [Abstract][Full Text] [Related]
25. N-linked glycosylation of the thyroid Na+/I- symporter (NIS). Implications for its secondary structure model.
Levy O; De la Vieja A; Ginter CS; Riedel C; Dai G; Carrasco N
J Biol Chem; 1998 Aug; 273(35):22657-63. PubMed ID: 9712895
[TBL] [Abstract][Full Text] [Related]
26. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
Schmutzler C; Köhrle J
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
[TBL] [Abstract][Full Text] [Related]
27. A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect.
Matsuda A; Kosugi S
J Clin Endocrinol Metab; 1997 Dec; 82(12):3966-71. PubMed ID: 9398697
[TBL] [Abstract][Full Text] [Related]
28. Anion selectivity by the sodium iodide symporter.
Van Sande J; Massart C; Beauwens R; Schoutens A; Costagliola S; Dumont JE; Wolff J
Endocrinology; 2003 Jan; 144(1):247-52. PubMed ID: 12488351
[TBL] [Abstract][Full Text] [Related]
29. Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization.
Dayem M; Basquin C; Navarro V; Carrier P; Marsault R; Chang P; Huc S; Darrouzet E; Lindenthal S; Pourcher T
J Endocrinol; 2008 Apr; 197(1):95-109. PubMed ID: 18372236
[TBL] [Abstract][Full Text] [Related]
30. Identification of a structural requirement for thyroid Na+/I- symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism.
Levy O; Ginter CS; De la Vieja A; Levy D; Carrasco N
FEBS Lett; 1998 Jun; 429(1):36-40. PubMed ID: 9657379
[TBL] [Abstract][Full Text] [Related]
31. Na+ coordination at the Na2 site of the Na+/I- symporter.
Ferrandino G; Nicola JP; Sánchez YE; Echeverria I; Liu Y; Amzel LM; Carrasco N
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5379-88. PubMed ID: 27562170
[TBL] [Abstract][Full Text] [Related]
32. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance.
Dohán O; De la Vieja A; Paroder V; Riedel C; Artani M; Reed M; Ginter CS; Carrasco N
Endocr Rev; 2003 Feb; 24(1):48-77. PubMed ID: 12588808
[TBL] [Abstract][Full Text] [Related]
33. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the thyroid Na+/I- symporter with an anti-COOH terminus antibody.
Levy O; Dai G; Riedel C; Ginter CS; Paul EM; Lebowitz AN; Carrasco N
Proc Natl Acad Sci U S A; 1997 May; 94(11):5568-73. PubMed ID: 9159113
[TBL] [Abstract][Full Text] [Related]
35. Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein.
Tonacchera M; Agretti P; de Marco G; Elisei R; Perri A; Ambrogini E; De Servi M; Ceccarelli C; Viacava P; Refetoff S; Panunzi C; Bitti ML; Vitti P; Chiovato L; Pinchera A
Clin Endocrinol (Oxf); 2003 Oct; 59(4):500-6. PubMed ID: 14510914
[TBL] [Abstract][Full Text] [Related]
36. Identification of in vivo phosphorylation sites and their functional significance in the sodium iodide symporter.
Vadysirisack DD; Chen ES; Zhang Z; Tsai MD; Chang GD; Jhiang SM
J Biol Chem; 2007 Dec; 282(51):36820-8. PubMed ID: 17913707
[TBL] [Abstract][Full Text] [Related]
37. Dietary I(-) absorption: expression and regulation of the Na(+)/I(-) symporter in the intestine.
Nicola JP; Carrasco N; Masini-Repiso AM
Vitam Horm; 2015; 98():1-31. PubMed ID: 25817864
[TBL] [Abstract][Full Text] [Related]
38. Sodium/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide.
Josefsson M; Grunditz T; Ohlsson T; Ekblad E
Acta Physiol Scand; 2002 Jun; 175(2):129-37. PubMed ID: 12028133
[TBL] [Abstract][Full Text] [Related]
39. Characterization of gastric Na+/I- symporter of the rat.
Kotani T; Ogata Y; Yamamoto I; Aratake Y; Kawano JI; Suganuma T; Ohtaki S
Clin Immunol Immunopathol; 1998 Dec; 89(3):271-8. PubMed ID: 9837697
[TBL] [Abstract][Full Text] [Related]
40. AMP-activated protein kinase activation leads to lysome-mediated NA(+)/I(-)-symporter protein degradation in rat thyroid cells.
Cazarin JM; Andrade BM; Carvalho DP
Horm Metab Res; 2014 May; 46(5):313-7. PubMed ID: 24691731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
